Methylprednisone Acetate

Verify with FDA CVM →

247 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
247
Total Reports
27
Deaths Reported
1090.0%
Death Rate

Active Ingredients

Methylprednisone Acetate

Administration Routes

UnknownParenteralSubcutaneousOralIntramuscular

Species Affected

Cat 137
Dog 110

Most Affected Breeds

Domestic Shorthair 90
Domestic Longhair 12
Crossbred Canine/dog 9
Domestic Mediumhair 9
Shih Tzu 8
Retriever - Labrador 8
Terrier - Yorkshire 7
Cat (unknown) 7
Chihuahua 7
Siamese 6

Most Reported Reactions

Emesis 77
Vomiting 54
Lethargy (see also Central nervous system depression in 'Neurological') 37
Lack of efficacy - NOS 22
Weight loss 19
Anorexia 18
Death 18
Behavioural disorder NOS 14
Diarrhoea 14
Seizure NOS 13
Other abnormal test result NOS 12
Lack of efficacy (ectoparasite) - flea 11

Outcome Breakdown

Recovered/Normal
121 (49.0%)
Outcome Unknown
52 (21.1%)
Ongoing
27 (10.9%)
Recovered with Sequela
20 (8.1%)
Died
20 (8.1%)
Euthanized
7 (2.8%)

Data Summary

Metric Value
Total adverse event reports 247
Reports involving death 27
Case-fatality rate (reported events) 1090.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Methylprednisone Acetate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 247 adverse event reports referencing Methylprednisone Acetate, including 27 reports in which the animal died — a 1090.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Methylprednisone Acetate. Reported administration routes include Unknown, Parenteral, Subcutaneous, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Methylprednisone Acetate reports are Cat (137 reports), Dog (110 reports), with Cat accounting for the largest share. Within those species, Domestic Shorthair (90), Domestic Longhair (12), Crossbred Canine/dog (9) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Methylprednisone Acetate are Emesis (77), Vomiting (54), Lethargy (see also Central nervous system depression in 'Neurological') (37), Lack of efficacy - NOS (22). Of the 247 reports with a coded outcome, Recovered/Normal is the leading category at 49.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Methylprednisone Acetate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial